Cargando…

Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort

BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not t...

Descripción completa

Detalles Bibliográficos
Autores principales: van Leeuwen, F.E., Klip, H., Mooij, T.M., van de Swaluw, A.M.G., Lambalk, C.B., Kortman, M., Laven, J.S.E., Jansen, C.A.M., Helmerhorst, F.M., Cohlen, B.J., Willemsen, W.N.P., Smeenk, J.M.J., Simons, A.H.M., van der Veen, F., Evers, J.L.H., van Dop, P.A., Macklon, N.S., Burger, C.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212878/
https://www.ncbi.nlm.nih.gov/pubmed/22031719
http://dx.doi.org/10.1093/humrep/der322
_version_ 1782216036774313984
author van Leeuwen, F.E.
Klip, H.
Mooij, T.M.
van de Swaluw, A.M.G.
Lambalk, C.B.
Kortman, M.
Laven, J.S.E.
Jansen, C.A.M.
Helmerhorst, F.M.
Cohlen, B.J.
Willemsen, W.N.P.
Smeenk, J.M.J.
Simons, A.H.M.
van der Veen, F.
Evers, J.L.H.
van Dop, P.A.
Macklon, N.S.
Burger, C.W.
author_facet van Leeuwen, F.E.
Klip, H.
Mooij, T.M.
van de Swaluw, A.M.G.
Lambalk, C.B.
Kortman, M.
Laven, J.S.E.
Jansen, C.A.M.
Helmerhorst, F.M.
Cohlen, B.J.
Willemsen, W.N.P.
Smeenk, J.M.J.
Simons, A.H.M.
van der Veen, F.
Evers, J.L.H.
van Dop, P.A.
Macklon, N.S.
Burger, C.W.
author_sort van Leeuwen, F.E.
collection PubMed
description BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not treated with IVF. In 1997–1999, data on reproductive risk factors were obtained from 65% of women and data on subfertility (treatment) were obtained from the medical records. The incidence of ovarian malignancies (including borderline ovarian tumours) through 2007 was assessed through linkage with disease registries. The risk of ovarian malignancies in the IVF group was compared with risks in the general population and the subfertile comparison group. RESULTS: After a median follow-up of 14.7 years, the risk of borderline ovarian tumours was increased in the IVF group compared with the general population [standardized incidence ratio (SIR) = 1.76; 95% confidence interval (CI) = 1.16–2.56]. The overall SIR for invasive ovarian cancer was not significantly elevated, but increased with longer follow-up after first IVF (P = 0.02); the SIR was 3.54 (95% CI = 1.62–6.72) after 15 years. The risks of borderline ovarian tumours and of all ovarian malignancies combined in the IVF group were significantly increased compared with risks in the subfertile comparison group (hazard ratios = 4.23; 95% CI = 1.25–14.33 and 2.14; 95% CI = 1.07–4.25, respectively, adjusted for age, parity and subfertility cause). CONCLUSIONS: Ovarian stimulation for IVF may increase the risk of ovarian malignancies, especially borderline ovarian tumours. More large cohort studies are needed to confirm these findings and to examine the effect of IVF treatment characteristics.
format Online
Article
Text
id pubmed-3212878
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-32128782011-11-10 Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort van Leeuwen, F.E. Klip, H. Mooij, T.M. van de Swaluw, A.M.G. Lambalk, C.B. Kortman, M. Laven, J.S.E. Jansen, C.A.M. Helmerhorst, F.M. Cohlen, B.J. Willemsen, W.N.P. Smeenk, J.M.J. Simons, A.H.M. van der Veen, F. Evers, J.L.H. van Dop, P.A. Macklon, N.S. Burger, C.W. Hum Reprod Original Articles BACKGROUND: Long-term effects of ovarian stimulation for IVF on the risk of ovarian malignancies are unknown. METHODS: We identified a nationwide historic cohort of 19 146 women who received IVF treatment in the Netherlands between 1983 and 1995, and a comparison group of 6006 subfertile women not treated with IVF. In 1997–1999, data on reproductive risk factors were obtained from 65% of women and data on subfertility (treatment) were obtained from the medical records. The incidence of ovarian malignancies (including borderline ovarian tumours) through 2007 was assessed through linkage with disease registries. The risk of ovarian malignancies in the IVF group was compared with risks in the general population and the subfertile comparison group. RESULTS: After a median follow-up of 14.7 years, the risk of borderline ovarian tumours was increased in the IVF group compared with the general population [standardized incidence ratio (SIR) = 1.76; 95% confidence interval (CI) = 1.16–2.56]. The overall SIR for invasive ovarian cancer was not significantly elevated, but increased with longer follow-up after first IVF (P = 0.02); the SIR was 3.54 (95% CI = 1.62–6.72) after 15 years. The risks of borderline ovarian tumours and of all ovarian malignancies combined in the IVF group were significantly increased compared with risks in the subfertile comparison group (hazard ratios = 4.23; 95% CI = 1.25–14.33 and 2.14; 95% CI = 1.07–4.25, respectively, adjusted for age, parity and subfertility cause). CONCLUSIONS: Ovarian stimulation for IVF may increase the risk of ovarian malignancies, especially borderline ovarian tumours. More large cohort studies are needed to confirm these findings and to examine the effect of IVF treatment characteristics. Oxford University Press 2011-12 2011-10-26 /pmc/articles/PMC3212878/ /pubmed/22031719 http://dx.doi.org/10.1093/humrep/der322 Text en © The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
spellingShingle Original Articles
van Leeuwen, F.E.
Klip, H.
Mooij, T.M.
van de Swaluw, A.M.G.
Lambalk, C.B.
Kortman, M.
Laven, J.S.E.
Jansen, C.A.M.
Helmerhorst, F.M.
Cohlen, B.J.
Willemsen, W.N.P.
Smeenk, J.M.J.
Simons, A.H.M.
van der Veen, F.
Evers, J.L.H.
van Dop, P.A.
Macklon, N.S.
Burger, C.W.
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title_full Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title_fullStr Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title_full_unstemmed Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title_short Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort
title_sort risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large dutch cohort
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212878/
https://www.ncbi.nlm.nih.gov/pubmed/22031719
http://dx.doi.org/10.1093/humrep/der322
work_keys_str_mv AT vanleeuwenfe riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT kliph riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT mooijtm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT vandeswaluwamg riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT lambalkcb riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT kortmanm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT lavenjse riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT jansencam riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT helmerhorstfm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT cohlenbj riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT willemsenwnp riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT smeenkjmj riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT simonsahm riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT vanderveenf riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT eversjlh riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT vandoppa riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT macklonns riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort
AT burgercw riskofborderlineandinvasiveovariantumoursafterovarianstimulationforinvitrofertilizationinalargedutchcohort